Showing results 1 - 10 of 23 for Chang Tsi
2017 could easily be one of the most impactful years for pharmaceutical development in China, depending on how well 2018 fares. Michelle Ko explores why.
The past few years have marked significant progress in the IP landscape in China, and some key individuals have played - and will continue to play - no small part in the strides forward. Asia IP looke...
After learning how software patents operate in the business world, let’s see how different patent offices handle them. Johnny Chan reports.
The Perfect Line   2016-11-30
Parallel imports are a huge issue for brands. Johnny Chan asks lawyers from Asia’s main manufacturing jurisdictions about how they monitor their supply chains.
Product Strange   2016-11-30
Finished products and raw materials alike can flow out of poorly-managed supply chains and sold in other countries as parallel imports, but many lawyers say legislation is insufficient to tackle the i...
Page: 1 2 3